Skip to main content

VaccinatioNCelebration Heralds NC Flu Shot Milestone

Now is the best time to sign up for your flu shot, and this is the best place to do it. When you reserve a 10-minute “NC Big Shot" slot on the North Carolina Biotechnology Center’s website for the Tuesday, October 4 VaccinatioNCelebration, it’ll reserve your free ticket to participate in a milestone of medicine.

Humacyte Gets $10M Boost for Clinical Trial

Humacyte, a regenerative medicine company based in Morrisville, has received a $9.9 million investment from the California Institute for Regenerative Medicine (CIRM) to support a clinical trial of its potential treatment for kidney disease.

Companies Leverage NCBiotech Loans for Big Investments

The latest company loans awarded by the North Carolina Biotechnology Center in the fourth quarter of FY 2016 bring to 189 the number of North Carolina bioscience companies that have received funding from the Center since its inception in 1984. The companies have received 276 loans totaling just under $34 million.

NCBiotech Awards $2.5M in Latest Quarter, $7.5M for Year

The North Carolina Biotechnology Center awarded 36 loans and grants totaling nearly $2.5 million to universities and bioscience companies during the fourth quarter of its 2015-2016 fiscal year ending June 30.

Partners Support NCBiotech’s Ag Biotech Industry in the Classroom Workshops

Four organizations -- BASF, Bayer, the Monsanto Fund and Syngenta – have provided $6,500 each to the North Carolina Biotechnology Center to support the summer 2016 Ag Biotech Industry in the Classroom program.

NC Life Science Growth Eclipses National Rise Again

North Carolina’s life science jobs continue to grow at more than triple the national average, pushing the total number of people employed in the sector statewide above 70,000 for the first time.

NC's Booming with International Bioscience Companies

Seventy-one companies headquartered in 20 countries now have a presence in North Carolina, employing more than 17,000 people in the state, where they have made capital investments totaling well over $2.5 billion in the past five years alone.

Indian Generic Drug Maker Plans $32M Durham HQ

Global generic drug maker Aurobindo Pharma said today it will invest over $31.7 million to establish a new national headquarters in Durham that will  bring 275 new R&D and pharmaceutical manufacturing jobs to the Triangle.

NCBiotech Awards $2.5 Million in Latest Quarter

The North Carolina Biotechnology Center awarded 21 grants and loans totaling $2.5 million to companies, universities and nonprofit organizations across the state during the third quarter of its 2015-2016 fiscal year ending March 31.

Bayer Engages Students in Ag Biotech Education

Bayer's crop science division hosted more than 160 fifth graders and high school students from central North Carolina this week at its Research Triangle Park campus, letting the students tour facilities, talked with Bayer staff and participate in hands-on exercises demonstrating how new crop seeds and ag chemicals move from an idea in someone’s mind to a product used in a farmer’s field.


Subscribe to RSS - About Us